<- Go Home

Titan Pharmaceuticals, Inc.

Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases in the United States and internationally.

Market Cap

$3.3M

Volume

6.7K

Cash and Equivalents

$4.1M

EBITDA

-$7.1M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

-$907.0K

Profit Margin

-30233.33%

52 Week High

$14.80

52 Week Low

$3.51

Dividend

N/A

Price / Book Value

0.83

Price / Earnings

-0.55

Price / Tangible Book Value

0.83

Enterprise Value

-$763.2K

Enterprise Value / EBITDA

0.11

Operating Income

-$7.1M

Return on Equity

-368.99%

Return on Assets

-172.63

Cash and Short Term Investments

$4.1M

Debt

N/A

Equity

$4.0M

Revenue

$3.0K

Unlevered FCF

-$5.2M

Sector

Pharmaceuticals

Category

N/A

Company Stock Pitches